|
|
|
Insider
Information: |
Eastbourne Capital Management Llc/ca |
Relationship: |
10% Owner |
City: |
San Rafael |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
44,385,290 |
|
Indirect Shares
|
48,092,752 |
|
|
Direct
Value |
$946,316,395 |
|
|
Indirect Value
|
$542,698,977 |
|
|
Total
Shares |
92,478,042 |
|
|
Total
Value |
$1,489,015,372 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2009-09-29 |
3,230,204 |
2007-12-31 |
10,901,174 |
Premium* |
|
Mabvax Therapeutics Holdings Inc |
MBVX |
10% Owner |
2009-09-30 |
11,850,000 |
2010-05-10 |
1,532,709 |
Premium* |
|
Amylin Pharmaceuticals Inc |
AMLN |
10% Owner |
2009-09-17 |
13,346,120 |
2007-12-31 |
20,220,126 |
Premium* |
|
MGIC Investment Corp |
MTG |
10% Owner |
2009-09-16 |
10,299,755 |
2009-03-11 |
15,438,743 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
10% Owner |
2010-03-04 |
5,659,211 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
88 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-15 |
4 |
B |
$29.24 |
$840,510 |
D/D |
28,689 |
21,506,439 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-16 |
4 |
B |
$30.78 |
$599,317 |
D/D |
19,471 |
21,525,901 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-17 |
4 |
B |
$30.35 |
$1,517,500 |
D/D |
50,000 |
21,575,901 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-21 |
4 |
B |
$28.52 |
$25,521,703 |
D/D |
894,000 |
22,469,910 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-30 |
4 |
B |
$27.72 |
$9,886,393 |
D/D |
356,652 |
22,826,562 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-05-07 |
4 |
B |
$27.88 |
$6,976,615 |
D/D |
250,000 |
23,076,562 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-06-06 |
4 |
B |
$29.91 |
$4,489,000 |
D/D |
150,000 |
23,226,562 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2008-06-23 |
4 |
S |
$1.26 |
$5,368,884 |
D/D |
(4,261,019) |
11,475,000 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-08-27 |
4 |
S |
$20.07 |
$128,143,018 |
D/D |
(6,026,562) |
17,200,000 |
0 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2008-12-29 |
4 |
B |
$0.30 |
$48,176 |
D/D |
146,571 |
11,621,571 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2008-12-30 |
4 |
B |
$0.34 |
$146,783 |
D/D |
414,814 |
12,036,385 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2008-12-31 |
4 |
B |
$0.36 |
$178,766 |
D/D |
485,690 |
12,522,075 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-01-02 |
4 |
B |
$0.35 |
$42,894 |
D/D |
111,466 |
12,633,541 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-01-05 |
4 |
B |
$0.38 |
$10,133 |
D/D |
26,343 |
12,659,884 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-01-13 |
4 |
B |
$0.40 |
$15,908 |
D/D |
40,273 |
12,700,157 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-01-15 |
4 |
B |
$0.45 |
$40,149 |
D/D |
87,485 |
12,787,642 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-01-20 |
4 |
B |
$0.45 |
$13,491 |
D/D |
29,566 |
12,817,208 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-01-22 |
4 |
B |
$0.45 |
$157,911 |
D/D |
322,809 |
13,140,017 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-01-27 |
4 |
B |
$0.46 |
$28,995 |
D/D |
62,649 |
13,202,666 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-01-28 |
4 |
B |
$0.48 |
$243 |
D/D |
511 |
13,203,177 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-01-29 |
4 |
B |
$0.46 |
$3,494 |
D/D |
7,500 |
13,210,677 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-01-30 |
4 |
B |
$0.46 |
$6,196 |
D/D |
13,617 |
13,224,294 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-02-02 |
4 |
B |
$0.46 |
$14,178 |
D/D |
31,160 |
13,255,454 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-02-10 |
4 |
B |
$0.46 |
$19,765 |
D/D |
43,440 |
13,298,894 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-02-11 |
4 |
B |
$0.46 |
$10,229 |
D/D |
22,482 |
13,321,376 |
2.37 |
- |
|
88 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|